Biomarkers for myocardial ischemia

摘要

This invention relates, e.g., to a method for determining if a subject has myocardial ischemia, comprising (a) providing a blood sample obtained from a subject suspected of having myocardial ischemia; (b) determining in the sample the amount of one or more of the following proteins: (i) Lumican and/or (ii) Extracellular matrix protein 1 and/or (iii) Carboxypeptidase N; and (c) comparing the amount(s) of the protein(s) to a baseline value that is indicative of the amount of the protein in a subject that does not have myocardial ischemia, wherein a statistically significantly increased amount of the protein(s) compared to the baseline value is indicative of myocardial ischemia. Other proteins indicative of myocardial ischemia are also described, as are methods for treating a subject based on a diagnostic procedure of the invention, and kits for carrying out a method of the invention.

主权项

1. A kit for detecting the presence of myocardial ischemia in a subject, comprising reagents for detecting the amount of at least three of the following proteins:
i) Lumican, and/or ii) Extracellular matrix protein 1, and/or iii) Carboxypeptidase N, and/or iv) Angiogenin, and/or v) Semenogelin, and/or vi) Long palate, lung and nasal epithelium carcinoma-associated protein 1, and/or vii) Perioxiredoxin isoform 2, and/or viii) Syntaxin 3, and/or ix) S100 isoform A7, and/or x) S100 isoform A8, and/or xi) S100 isoform A9, and/or xii) Sortilin-related receptor, and/or xiii) Catalase, and/or xiv) Low density lipoprotein receptor related protein 1, and/or xv) Low density lipoprotein receptor related protein 2.